Arcutis Biotherapeutics (ARQT) Receivables (2022 - 2026)
Arcutis Biotherapeutics' Receivables was $155.16 million in Q2 2026, up 45.4% from $106.69 million a year earlier and up 7.5% from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Receivables (2022 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Arcutis Biotherapeutics came in at $146.23 million, up 100.1% from FY2024.
- Receivables has now increased for three consecutive years, with a three-year compound annual growth rate of 158.6% (FY2022 to FY2025).
- In earlier years, Receivables was $73.07 million in FY2024 (+183.1%), $25.81 million in FY2023 (+205.1%) and $8.46 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Receivables in data going back to Q3 2022.
- Compared with a year earlier, Receivables has increased for 12 straight quarters, with growth averaging 121.8% over the last eight quarters.
- The year-over-year growth in Receivables has ranged between 45.4% (Q2 2026) and 698.7% (Q3 2023) over the last five years.
- Per Business Quant data, ARQT's Receivables in the three quarters before Q2 2026 was $144.38 million (Q1 2026), $146.23 million (Q4 2025) and $115.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Arcutis Biotherapeutics | 3.43 Bn | 2.72 Bn | 118.92 Mn | 155.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 155.16 Mn |
| Mar 31, 2026 | 144.38 Mn |
| Dec 31, 2025 | 146.23 Mn |
| Sep 30, 2025 | 115.12 Mn |
| Jun 30, 2025 | 106.69 Mn |
| Mar 31, 2025 | 85.42 Mn |
| Dec 31, 2024 | 73.07 Mn |
| Sep 30, 2024 | 60.12 Mn |
| Jun 30, 2024 | 43.41 Mn |
| Mar 31, 2024 | 37.15 Mn |
| Dec 31, 2023 | 25.81 Mn |
| Sep 30, 2023 | 19.42 Mn |
| Jun 30, 2023 | 17.21 Mn |
| Mar 31, 2023 | 12.77 Mn |
| Dec 31, 2022 | 8.46 Mn |
| Sep 30, 2022 | 2.43 Mn |
API Access
Arcutis Biotherapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();